PXS Collaborators Receive Government Grants of $1.4m
Filed with ASX · · 3 pages · English
Earlier from Syntara
- Share Purchase Plan
- Security Purchase Plan
- FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study
- Appendix 4C Cash Flow Report
- PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial
Later from Syntara
- Response to ASX Aware Query
- Appendix 4C Quarterly Cash Flow Report
- Clarification Announcement
- Aptar Pharma Pays PXS Us$5m to Acquire Orbital Technology
- PXS to Receive Stg2.9m from Parkinsons UK for New Trial
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara